Athanor Capital’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-26,680
Closed -$1.59M – 727
2020
Q2
$1.59M Buy
+26,680
New +$1.65M 0.08% 132
2020
Q1
– Sell
-7,300
Closed -$400K – 420
2019
Q4
$400K Sell
7,300
-3,200
-30% -$119K 0.02% 275
2019
Q3
$297K Buy
+10,500
New +$385K 0.02% 192

Other funds holding PRNB

Athanor Capital's PRNB Position: Q3 2020 in Review

Athanor Capital sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 26,680 shares — an estimated $1.59M sold.

Athanor Capital first reported a position in PRNB in Q3 2019 and held it in 3 quarters. The position peaked at $1.59M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Athanor Capital reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Athanor Capital sold 26,680 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $1.59M.
  • Athanor Capital first reported a position in Principia Biopharma Inc. Common Stock in Q3 2019 and held it in 3 quarters.
  • Athanor Capital's Principia Biopharma Inc. Common Stock position peaked at $1.59M in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Athanor Capital's 13F filing for Q3 2020, filed 16 Nov 2020.